Pfizer and its partner BioNTech plan to file for FDA emergency approval for its coronavirus vaccine on Friday.

The two companies confirmed their intention to file on Friday in a statement released Friday morning.

Pfizer and BioNTech are currently in Phase 3 trials on the vaccine as is fellow pharmaceutical giant, Moderna.

Follow below for updates on the coronavirus. Mobile users click here.